Emerging therapies for hemophilia: controversies and unanswered questions [version 1; referees: 4 approved]
Several new therapies for hemophilia have emerged in recent years. These strategies range from extended half-life factor replacement products and non-factor options with improved pharmacokinetic profiles to gene therapy aiming for phenotypic cure. While these products have the potential to change he...
| Published in: | F1000Research |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-04-01
|
| Online Access: | https://f1000research.com/articles/7-489/v1 |